A client expresses his desire to execute a living will while he is in a period of remission from schizoaffective disorder. What is one difference between the living will and the durable power of attorney?
A living will is legally binding in all 50 states.
A durable power of attorney is legally binding in all 50 states.
The living will makes provisions for financial decisions.
A living will is also known as a healthcare proxy.
The Correct Answer is B
Choice A reason: A living will is a legal document that specifies a person's wishes regarding medical treatment in situations where they are unable to communicate their decisions. However, it is not uniformly recognized or enforceable in all 50 states, as the exact requirements and legal weight of a living will can vary by state.
Choice B reason: A durable power of attorney (DPOA) for healthcare is recognized in all 50 states. It allows a designated agent to make healthcare decisions on behalf of the individual if they are incapacitated, providing a consistent and legally enforceable method of decision-making across the country.
Choice C reason: A living will does not typically address financial matters. It is specifically focused on healthcare decisions, such as the use of life-sustaining treatment, resuscitation, and palliative care preferences. Financial matters are addressed separately, often through a general durable power of attorney or estate planning documents.
Choice D reason: A living will is distinct from a healthcare proxy. While both relate to healthcare decisions, a healthcare proxy (or medical power of attorney) designates an agent to make decisions on the individual's behalf, whereas a living will documents specific treatment preferences directly.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Family therapy focused on child management skills is evidence-based for ODD. It trains parents to use consistent discipline, positive reinforcement, and behavioral strategies to manage oppositional behaviors effectively, directly targeting the core problems of the disorder.
Choice B reason: Structural family therapy emphasizes family hierarchy and multigenerational patterns but is less directly focused on behavioral management of ODD in children.
Choice C reason: Cognitive behavioral therapy can help the child recognize thoughts and behaviors but is less effective if parents are not simultaneously trained in behavior management techniques, which are critical in ODD.
Choice D reason: Family systems therapy with integrated behavior modification may be helpful, but the primary evidence supports targeted parent-focused behavioral management as most effective for ODD.
Correct Answer is C
Explanation
Choice A reason: Sertraline, an SSRI, is primarily used for anxiety and depression and is not indicated for aggression in children with ASD.
Choice B reason: Carbamazepine is an anticonvulsant used for mood stabilization or seizure disorders but is not first-line for irritability or aggression in ASD.
Choice C reason: Risperidone is FDA-approved for the treatment of irritability, aggression, and behavioral disturbances in children with ASD, making it the most evidence-based pharmacologic choice for this patient.
Choice D reason: Venlafaxine, an SNRI, is used for depression and anxiety but has limited evidence for aggression management in pediatric ASD.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.